Aethlon Medical (AEMD) Return on Equity (2011 - 2026)

Aethlon Medical's Return on Equity history runs 16 years deep, the most recent figure standing at 0.01% for Q1 2026.

• For the quarter ending Q1 2026, Return on Equity rose 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 1.0% YoY), and the FY2026 full-year result was 0.01%, up 1.0% from the prior year.
• Return on Equity was 0.01% for Q1 2026 at Aethlon Medical, down from 0.01% in the prior quarter.
• Over the last five years, Return on Equity for AEMD reached as high as 0.01% in Q1 2022 and fell as low as 0.02% in Q2 2025.
• Median Return on Equity over the past 5 years was 0.01% (2026), compared with a mean of 0.01%.
• Across the five-year window, Return on Equity fell 1 bps in 2023 and grew 1 bps in 2025, its largest moves.
• Over 5 years, Return on Equity stood at 0.01% in 2022, then plunged by 92 bps to 0.01% in 2023, then sank by 35 bps to 0.02% in 2024, then soared by 37 bps to 0.01% in 2025, then fell by 8 bps to 0.01% in 2026.
• Business Quant data shows AEMD's Return on Equity at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.